microFIND TM
Tethis develops in vitro diagnostic device for genome investigation based on its state-of-the-art nanocoating technology.
microFINDTM is an innovative device for the detection of genetic aberration by means of Fluorescent in Situ Hybridization (FISH) technology.
microFINDTM allows to perform different tests for the screening of some tumour pathologies such as onco-hematological diseas, bladder and cervical cancer.
microFINDTM is specifically designed to address FISH on interphase nuclei from cytological suspensions (e.g.: blood, bone marrow and urine specimen)
microFINDTM upraises FISH methodology to a more cost affordable and easy-to-apply technique, through the following major points of strength:
- Creates an innovative approach to conventional FISH - microFINDTM brings chemical into slide through a miniaturized device
- Multi FISH protocol/specimen for a single slide
- Allows a significant reduction of chemicals consumption due to a miniaturization of the sample analysis area (impressive cost reduction)
- More cells per single frame (reduced time for images acquisition)
- Unique protocol to analyze scarce cells specimens
- Unique protocol for FISH starting from living cells specimens
- Full automation of FISH protocol with an easy-to-use systems for large scale screening